TITLE

Effect of inhaled glucocorticoids on IL-1β and IL-1 receptor antagonist (IL-1ra) expression in asthmatic bronchial epithelium

AUTHOR(S)
Sousa, Ana R.; Trigg, Cecilia J.; Lane, Stephen J.; Hawksworth, Richard; Nakhosteen, John A.; Poston, Robin N.; Lee, Tak H.
PUB. DATE
May 1997
SOURCE
Thorax;May1997, Vol. 52 Issue 5, p407
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66296757

 

Related Articles

  • IL-1RA gene-transfected bone marrow-derived mesenchymal stem cells in APA microcapsules could alleviate rheumatoid arthritis. Jianhua Hu; Hongjian Li; Guanhao Chi; Zhao Yang; Yi Zhao; Wei Liu; Chao Zhang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 1, p706 

    Objectives: In order to investigate the encapsulation of interleukin 1 receptor antagonist (IL-RA) genemodified mesenchymal stem cells (MSCs) in alginate-poly-L-lysine (APA) microcapsules for the persistent delivery of interleukin 1 receptor antagonist (IL-RA) to treat Rheumatoid arthritis (RA)....

  • Absence of C/EBPα may cause bronchial smooth muscle proliferation in asthma. Rahman, N. M. // Thorax;Apr2005, Vol. 60 Issue 4, p281 

    The article states that proliferation of bronchial smooth muscle (BSM) cells occurs in the airways of asthmatic patients. Glucocorticoid s exerts antiproliferative effects via C CAAT/enhancer binding protein (C/EBPcz), an antiproliferative transcription factor. This paper studies signalling...

  • Interleukin-20 Promotes Airway Remodeling in Asthma. Gong, Wenbin; Wang, Xin; Zhang, Yuguo; Hao, Junqing; Xing, Chunyan; Chu, Qi; Wang, Guicheng; Zhao, Jiping; Wang, Junfei; Dong, Qian; Liu, Tian; Zhang, Yuanyuan; Dong, Liang // Inflammation;Dec2014, Vol. 37 Issue 6, p2099 

    Previous studies have demonstrated that interleukin-20 (IL-20) is a pro-inflammatory cytokine, and it has been implicated in psoriasis, lupus nephritis, rheumatoid arthritis, atherosclerosis, and ulcerative colitis. Little is known about the effects of IL-20 in airway remodeling in asthma. The...

  • Glucocorticoid Receptor-Beta Up-Regulation and Steroid Resistance Induction by IL-17 and IL-23 Cytokine Stimulation in Peripheral Mononuclear Cells. Vazquez-Tello, Alejandro; Halwani, Rabih; Hamid, Qutayba; Al-Muhsen, Saleh // Journal of Clinical Immunology;Feb2013, Vol. 33 Issue 2, p466 

    Purpose: Most asthmatic patients have well controlled symptoms with regular treatment, but some require much higher doses of inhaled and oral corticosteroids, or in rare cases fail to respond; these patients may present Th-17 cell infiltration and associated cytokines (IL-17A and -F) in the...

  • Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Velden, V. H. J. Van Der // Mediators of Inflammation;Aug98, Vol. 7 Issue 4, p229 

    GLUCOCORTICOIDS are potent inhibitors of inflammatory processes and are widely used in the treatment of asthma. The anti-inflammatory effects are mediated either by direct binding of the glucocorticoid/glucocorticoid receptor complex to glucocorticoid responsive elements in the promoter region...

  • Vitamin D3 and response to glucocorticoids in steroid resistant asthmatics. Kon, S. // Thorax;May2006, Vol. 61 Issue 5, p375 

    The article examines the effect of vitamin D3 and glucocorticoid therapy in steroid resistant asthmatics. The study shows that human interleukin (IL)-10 secreting regulatory T cells have the capacity to inhibit the immune response implicated in the pathogenesis of athma. It was shown also that...

  • Interleukin-33 in asthma: insights into pro-inflammatory roles of airway structural cells. Préfontaine, D.; Al-Awan, L.; Awan, A. K.; Audusseau, S.; Lajoie-Kadoch, S.; Olivenstein, R.; Chakir, J.; Halayko, A. J.; Lemière, C.; Martin, J. G.; Hamid, Q. // Allergy, Asthma & Clinical Immunology;2010 Supplement 1, Vol. 6 Issue S1, p1 

    Background Interleukin-33 (IL-33) is a novel cytokine that triggers inflammatory immune responses, but evidence of its role in human asthma, a common allergic airway disease, is lacking. There is also a paucity of information regarding which cells express IL-33, and what conditions promote its...

  • Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33. Calvén, Jenny; Akbarshahi, Hamid; Menzel, Mandy; Ayata, Cemil Korcan; Idzko, Marco; Bjermer, Leif; Uller, Lena // Journal of Translational Medicine;Aug2015, Vol. 13 Issue 1, p1 

    Background: Bronchial smooth muscle cells (BSMCs) from severe asthmatics have been shown to overexpress the Th2-driving and asthma-associated cytokine IL-33. However, little is known regarding factors involved in BSMC production of IL-33. Rhinovirus (RV) infections cause asthma exacerbations,...

  • Bronchial macrophages in asthmatics reveal decreased CD16 expression and substantial levels of receptors for IL-10, but not IL-4 and IL-7. Moniuszko, Marcin; Bodzenta-Łukaszyk, Anna; Kowal, Krzysztof; Dąbrowska, Milena // Folia Histochemica et Cytobiologica;2007, Vol. 45 Issue 3, p181 

    The role of different subpopulations of bronchial macrophages (BMs) in asthma pathogenesis has not yet been completely elucidated. In addition, little is known about potential in vivo responsiveness of BMs to pro- and anti-inflammatory cytokines present in the bronchial milieu. We aimed to...

  • EFFECTS OF IL-13 ON NORMAL AND ASTHMATIC PAEDIATRIC BRONCHIAL EPITHELIAL CELLS: IL-13 AS A THERAPEUTIC TARGET IN CHILDHOOD ASTHMA.  // Thorax;Dec2008 Supplement 7, Vol. 63, pA33 

    An abstract of the article "Effects of IL-13 on Normal and Asthmatic Paediatric Bronchial Epithelial Cells: IL-13 As a Therapeutic Target in Childhood Asthma," by colleagues is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics